day 1 agenda

12th Global Insight Conference on Breast Cancer 
Day -1: July(07, 2025)
Meeting Hall-I
Registrations Open (08:00-08:45)
Opening Ceremony (08:45-09:00)
Moderator
Jessica Burgers, Holy Cross Health, USA
Keynote Talks
09:00-09:30 Title: TFEB is a master regulator of tumor-associated macrophages in breast cancer
Daping Fan, University Of South Carolina, USA
 
09:30-10:00 Title: Context-Responsive Nanomedicine in Targeted CRISPR/Cas9 Therapy for Basal Like Breast Cancer
Dipanjan Pan, The Pennsylvania State University, USA
   
10:00-10:30 Title: Distinct Tumor Immune Responses to Nanosecond Pulsed Electric Fields (nsPEFs) Determine Immunity
Stephen Jack Beebe, Old Dominion University, USA
   
 Group Photo
10:30-10:45 ---Refreshment Break @ Foyer  
   
SCIENTIFIC SESSION-I

Session Chair: Hanna Romanska-Knight, Medical University of Lodz, Poland

 
   
10:45-11:05 Title: Modern Management of the Axilla in Breast Cancer
Rizzo Monica, Emory University School of Medicine, USA
   
11:05-11:25 Title: Breast Cancer Screening in the Elderly United States Population: Challenges and Future Considerations
Jessica Burgers, Holy Cross Health, USA
   
11:25-11:45 Title: Comparing Narrow and Wide Angle Digital Breast Tomosynthesis
Tanya W. Moseley, The University of Texas MD Anderson Cancer Center, USA
   
11:45-12:05 Title: The Molecular Mechanisms behind Advanced Breast Cancer: Metabolic Reprogramming and Alternate Translation
Columba De La Parra, Lehman College- City University of New York, USA
   
12:05-12:25 Title: The effect of deuterium depletion on the survival outcomes of cancer patients and recurrence of the disease
Gábor Somlyai, HYD LLC for Cancer Research and Drug Development, Hungary
   
12:25-12:45                      SPEAKER SLOT AVAILABLE
 
  Networking & Panel Discussion
12:45-13:45  Lunch Break @ Restaurant 
SCIENTIFIC SESSION-II

Session Chairs:
Dipanjan Pan, The Pennsylvania State University, USA
&
Amy S. Yee, Tufts University School of Medicine, USA
   
13:45-14:05 Title: The Wu-Kolassa Estimator in Restricted Mean Survival Time Analysis: Reducing Bias and Enhancing Power in Oncology Survival Studies
Yaoshi Wu, AstraZeneca, USA
   
14:05-14:25 Title: The Revolution in Understanding Breast Cancer Recurrences
Howard Petty, University of Michigan, USA
 
14:25-14:45 Title: Technological Innovations Enable the 24-hour Discharge of Patients Who Undergo Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction: Safety and Aesthetic Outcomes from A Single-Centre, Prospective Cohort Study
Zhenggui Du, West China Hospital of Sichuan University, Sofia, China
   
14:45-15:05 Title: A Precision engineered approach based on modular assembly for in vitro expansion of low-abundance antigen-specific T cells   
Zhangyong Hong, Nankai University, China
   
15:05-15:45 Title: Can Fraction-B from Catfish Skin be Used Successfully for the Treatment of Breast Cancer and for Healing Wounds Cosmetically After Breast Cancer Surgery?
Jassim Al-Hassan, Kuwait University, Kuwait
 
15:45-16:05 Title: Postoperative outcomes of minimally-invasive nipple-sparing mastectomy with immediate breast reconstruction versus conventional approach in women with early breast cancer – a single centre experience
Marc Ong Weijie, Khoo Teck Puat Hospital, Singapore
   
16:05-16:15  Refreshment Break
   
16:15-16:35 Title: FGF/FGFR-Signaling in response to therapy in triple-positive breast cancer
Hanna Romanska-Knight, Medical University of Lodz, Poland
   
16:35-16:55 Title: The regulation of the triple-negative breast cancer microenvironment by the CD74/CD84-induced cascade   
Idit Shachar, Weizmannn Institute of Science, Israel
   
16:55-17:15 Title: Hypoxia modulates the XBP1s/HDAC2/EZH2-ΔNp63α axis to promote breast cancer metastasis independent of HIF1α
Zhixiong Jim Xiao, Sichuan University, China
   
17:15-17:35 Title: The effect of deuterium depletion on the survival outcomes of cancer patients and recurrence of the disease
Gábor Somlyai, HYD LLC for Cancer Research and Drug Development, Hungary
   
17:35-17:55 Title: MEMS-based biochips for electro-thermo-mechanical (ETM) phenotyping of breast biopsy tissues
Hardik Jeetendra Pandya, Indian Institute of Science, Bangalore, India
  Networking & Panel Discussion
Day-1 Concludes
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org 

day 2 agenda

Day -2: July(08, 2025)
Meeting Hall-I
Moderator
Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland
Keynote Talks
09:15-09:45 Title: Radioguided occult lesion localisation for non-palpable breast lesions in combination with radioisotope sentinel lymph node localisation (SNOLL) – 10 year experience of a single centre
Maged Hussien, Norfolk and Norwich University hospital, United Kingdom
 
09:45-10:15 Title: Poor oral health and cancer – why does it matter?
Jukka H. Meurman, University of Helsinki and Helsinki University, Finland
   
10:15-10:45 Title: The Luminous Pro Series (LPS Pink Luminous Breast), an LED-based technology utilizing patented red light wavelengths between 620–800 nanometers, demonstrated comparable sensitivity and specificity to mammography in detecting breast abnormalities
Marylin R Dans, Silkprousa, USA
   
10:45-11:00  Refreshment Break
SCIENTIFIC SESSION-III
Session Chairs: Halina Abramczyk, Lodz University of Technology, Poland
&
YuTe Liu, Chung Shan Medical University, Taiwan
   
11:00-11:20 Title: Identification of Novel Markers for TTK Inhibitor and Taxane Sensitivity in Triple-Negative Breast Cancer
Lei Duan, Rush University Medical Center, USA
   
11:20-11:40 Title: In vitro and in vivo effects of A traditional Chinese medicine (TCM) in human breast cancer cells
YuTe Liu, Chung Shan Medical University, Taiwan
 
11:40-12:00 Title: Growth inhibitory effect of Leptospermum scoparium (manuka) chloroform extract on breast and liver cancer cell lines
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
   
12:00-12:20 Title: Prevalence of Epidermal Growth Factors Receptors in Iraqi Patients with Non-Small Cell Lung Cancer
Saad Alomar, College of Medicine-University of Basra, Iraq
 
12:20-12:40 Title: Lumpectomy surgery for large ductal carcinoma in situ
Jacqueline Tsai, Stanford University School of Medicine, USA
 
12:40-13:00 Title: Entosis in breast cancer as regulated process depending on stage of cancer
Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland
 
Networking & Panel Discussion
13:00-13:50  Lunch Break @ Restaurant 
13:50-14:40  Poster Presentations
GICBC-101 Title: Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer
Wenfeng Zeng, Sun Yat Sen University, China
 
GICBC-102 Title: Case report of synchronous triple primary malignancies: bilateral breast cancer and rectal adenocarcinoma
Chiaching Yu, Taipei City Hospital, Taiwan
 
GICBC-103 Title: RGS4 and αSMA-expressing CAFs mediate immune escape via immunosuppressive mesenchymal network formation
Huiping Chen, Sun Yat Sen University, China
   
GICBC-104 Title: Application of artificial intellingence in cardio-oncology imaging for canver therapy-related cardiovascular toxicity: systematic review
Mohammed Hassan A Obaidan, Johns Hopkins Aramco Healthcare/ University College Dublin, Saudi Arabia
   
GICBC-105 Title: Wild-Type p53 Restrains CIP4 to Suppress Breast Cancer Metastatic Risk
Sohidul Islam, Academy of Scientific and Innovative Research, India
 
SCIENTIFIC SESSION-IV

Session Chairs: Lei Duan, Rush University Medical Center, USA
&
Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
 
14:40-15:00 Title: Detection of Circulating Tumor Cells by Cell Block Technique in Malignant Tumors       
Jahnvi Vijay, Rajiv Gandhi University of Health Sciences, India
 
15:00-15:20 Title: A new modality for cancer tracking - Raman imaging, nanoIR imaging, fluorescence and AFM studies combined with AI analysis   
Halina Abramczyk, Lodz University of Technology, Poland
 
15:20-15:40 Title: An Epigenetics-Plus Combinatorial Therapy That Enables Immune Checkpoint Susceptibility as a Novel Cold-to-Hot Drug.      
Amy S. Yee, Tufts University School of Medicine, USA
 
15:40-16:00 Title: Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer Treatment
Qi Wang, Norwich Medical School University, UK
 
16:00-16:20 Title:  Dissecting the Oncogenic Circuitry of miR-99b-5p in Breast Cancer: From Targetome to Tumor Regression
Bala Gür Dedeoglu, Ankara University, Turkey
 
16:20-16:30  Refreshment Break
 
16:30-16:50 Title: Expanding theranostics with ultrasound-mediated oncolytic virotherapy: at the crossroads of image guided gene therapy & immunotherapy to combat triple negative breast cancer
Candace Howard-Claudio, University of Mississippi Medical Center, USA
 
16:50-17:10 Title: Anticancer Potential of Black Ginseng Extract in a Breast Cancer Cell Xenograft Mouse Model   
Hye Jin Park, Kangwon National University, South Korea
 
17:10-17:30 Title:  Taking one more innovative step forward. Use of deepithelialized axio-perforator, bipedicled flap for immediate combined breast/nac reconstruction
Vagif Kalender (Galandarov), Azerbaijan Medical University, Azerbaijan
   
17:30-17:50 Title: Retrospective Analysis of Breast Cancer Presentation Among Young and Older Women inan Indian Cohort of 70 Patients
Neelesh Shrivastava, AIIMS Nagpur, India
   
17:50-18:10                      SPEAKER SLOT AVAILABLE
   
  Networking & Panel Discussion
Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org 

Virtual agenda

Day -2: July 08th, 2025
Time Zone: Central European Time (CET)
Virtual Presentations
07:45-08:05 Title: Breast cancer survivors, psychological distress and quality of life: a multifaceted model of healthcare 
Syeda Zakia Hossain, The University of Sydney, Australia
   
08:05-08:25 Title: Introducing Cosmosort: The Next Generation Spatial Cell Sorter
Haewook Jang, Meteorbiotech, South korea
   
08:25-08:45 Title: One stage single port endoscopic breast cancer reconstruction with Bra-flap technique and direct to implant : a four-year case series report of SmoothSilk implant
Tsung Chun Huang, China Medical University Hospital, Taiwan
   
08:45-09:05 Title: Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer
Nan-Haw Chow, China Medical University Hospital, Taiwan
   
09:05-09:25 Title: Microwave ablation treatment of non-lactating mastitis
Aili Saiding, Guangyuan Central Hospital, China
   
09:25-09:45 Title: The identification and potential mechanism of SET7/9 as a tumor biomarker in breast cancer
Wenzhe Si, Peking University Third Hospital, China
   
09:45-10:05 Title: CanAssist Breast: First Proteomics and Artificial Intelligence Based Cost-effective Prognostic Test: Real world data 
Manjiri Bakre, OncoStem Diagnostics Pvt Ltd, India
   
10:05-10:15 Title: SDG like Bioactive Constituent of C. gouriana Exhibits Anticancer Potential in Breast Cancer Cells      
Reena Jassal, Punjabi University, India
   
10:15-10:25 Title: Comparative Evaluation of Biological Activity of Anti-Breast Cancer Monoclonal Antibodies
Harish Chander, National Institute of Biologicals, India
   
10:25-10:45 Title: The impact of bitter taste genes TAS2R38 and CA6 and breast cancer risk
Dorota Lukasiewicz-Smietanska, National Research Institute, Poland
   
10:45-11:05 Title: Automatic detecting multiple bone metastases in breast cancer
Yali Xu, Peking Union Medical College Hospital, China
   
11:05-11:25 Title: Efficacy and safety of robotic-assisted versus endoscopic-assisted axillary lymph node dissection in node-positive breast cancer: a retrospective comparative study
Haiyan Li, The Sixth Affiliated Hospital of Sun Yat-sen University, China
   
11:25-11:45 Title: Factors Influencing Adherence to Endocrine Therapy After Breast Cancer Surgery   
Aina Johnsson, Karolinska Institutet, Sweden
   
11:45-12:05 Title: Metabolome-Microbiome cross-talk in CRD-induced mammary tumorigenesis
Tapasree Roy Sarkar, Texas A & M University, USA
   
12:05-12:25 Title: Radiomics and Machine Learning for Preoperative Differentiation of In Situ and Invasive Breast Cancer Using DCE–MRI
Luana Conte, University of Palermo, Italy
   
12:25-12:45 Title: Toll-like Receptor 2-targeted therapies ameliorate the efficacy of chemotherapy and immunotherapy in breast cancer
Laura Conti, University of Torino, Italy
   
12:45-13:05 Title: Curcumin and doxorubicin delivered by biocompatible clay-based nanomaterials to overcome multidrug resistance in breast cancer
Paola Poma, University of Palermo, Italy
   
13:05-13:25 Title: Sleep, physical activity, and sedentary behaviors in relation to breast cancer risk: results from a case-control study among Polish-born women in the US
Azam Najaf Kouchak, Michigan State University, USA
   
13:25-13:45 Title: Identification and characterization of a novel selective HDAC6 inhibitor against triple negative breast cancer
Elisabetta Panza, University of Naples Federico, Italy
   
13:45-14:05 Title: How we do it: Songket suture technique for lying half cone dog ear
Nur Qodir, University of Sriwijaya, Indonesia
   
14:05-14:25 Title: Novel therapeutic approaches in development for hormone receptor-positive metastatic breast cancer      
Richard Baird, University of Cambridge, UK
   
14:25-14:45 Title: Optimizing the Patient Experience for Women with Disabilities in the Breast Imaging Clinic
Jamie Spoont, University of Miami-Miller School of Medicine, USA
   
14:45-15:05 Title: Multi-modal microscopy for treatment of breast cancer cells with zirconium-based nano-particles
Herbert Schneckenburger, Aalen University, Germany
   
15:05-15:25 Title: Toxicity, half-life and antitumor activity of phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates: A novel family of antimitotic CYP1A1-targeted prodrugs in murine models
Atziri Corin Chavez Alvarez, Inserm-Université Clermont-Auvergne, France
   
15:25-16:05 Title: Breast Cancer Eradication by Steroid Receptor Coactivator-3 Deleted Regulaotry T Cells
Sang Jun Han, Baylor College of Medicine, USA
   
16:05-16:25 Title: Minimally Invasive Breast Cancer: How to Find Early Breast Cancers
Harnoor Singh, University of Texas at Houston, USA
   
16:25-16:45 Title: Differences in age, stage and biology of breast cancer presentations at a private breast unit in johannesburg before and during the covid-19 pandemic
Jung Su Yon, University of California, USA
   
16:45-17:05 Title: TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells
Stanley Lipkowitz, National Cancer Institute, USA
   
17:05-17:25 Title: Mammography-based Longitudinal Breast Cancer Risk Prediction Using a Temporal Multi-Modal Feature Fusion Framework
Haoyan Ding, UCLA, USA
Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to   breastcancer@innovinc.org 

Download